✦ LIBER ✦

Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection

✍ Scribed by Stout, Jason E

Book ID: 121314271
Publisher: Informa plc
Year: 2004
Tongue: English
Weight: 169 KB
Volume: 3
Category: Article
ISSN: 1474-0338
DOI: 10.1517/14740338.3.3.187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN1 HEPATOTOXICITY ASSOCIATED WITH RIFA

PIN1 HEPATOTOXICITY ASSOCIATED WITH RIFAMPIN AND PYRAZINAMIDE THERAPY OF LATENT TUBERCULOSIS INFECTION:A META-ANALYSIS

✍ S Ghosh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

High hepatotoxicity of pyrazinamide and

High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis

✍ Younossian, A. B. 📂 Article 📅 2005 🏛 European Respiratory Society 🌐 English ⚖ 159 KB

Two-month regimen of isoniazid, rifampin

Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection

✍ R. Duarte; A. Carvalho; A. Correia 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Update on the Treatment of Tuberculosis

Update on the Treatment of Tuberculosis and Latent Tuberculosis Infection

✍ Blumberg, Henry M. 📂 Article 📅 2005 🏛 American Medical Association 🌐 English ⚖ 176 KB

Present-day treatment of tuberculosis an

Present-day treatment of tuberculosis and latent tuberculosis infection

✍ Inés Pérez-Camacho; Antonio Rivero-Juárez; José María Kindelán; Antonio Rivero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Spanish ⚖ 163 KB

Rifampin in the Treatment of Drug-Resist

Rifampin in the Treatment of Drug-Resistant Mycobacterium tuberculosis Infections

✍ Vall-Spinosa, A.; Lester, William; Moulding, Thomas; Davidson, Paul T.; McClatch 📂 Article 📅 1970 🏛 Massachusetts Medical Society 🌐 English ⚖ 822 KB